What You Need to Know Ahead of Colgate-Palmolive Earnings Release
π Colgate-Palmolive is set to announce fiscal Q3 2026 results with analysts forecasting an adjusted EPS of $0.92.
π The company has exceeded Wall Street's earnings estimates in each of the last four quarters.
π Shares have soared 18.3% over the past 52 weeks, outpacing the S&P 500 and XLP ETF returns.
π° Analysts project adjusted EPS growth to $4.07 by fiscal 2027, up from $3.69 in fiscal 2025.
π‘οΈ The company benefits from high brand loyalty and a recovery in oral-care market share after 2025.
π΅ Colgate-Palmolive declared a quarterly dividend of $0.53 per share payable on November 13, 2026.
π Analysts maintain an average price target of $97.19, suggesting potential upside of 4.8% from current levels.
π The company maintains a powerful business model with an average gross margin of 60.5% over the past two years.
π§ Free cash flow margins have averaged 17.6% over the last two years, supporting growth and shareholder returns.
π Investor confidence has returned in 2026 driven by resilient demand for everyday essentials.
- Shares of Colgate-Palmolive have surged 18.3% over the past 52 weeks, significantly outperforming the S&P 500 and Consumer Staples ETF.
- The company has exceeded Wall Street's earnings estimates in each of the last four consecutive quarters.
- Analysts project adjusted EPS growth to $4.07 by fiscal 2027, indicating sustained profitability.
- Colgate-Palmolive declared a quarterly dividend of $0.53 per share, continuing an uninterrupted history dating back to 1895.
- The company has regained investor confidence in 2026 with improving earnings expectations and resilient demand.
- A recovery in oral-care market share following a challenging 2025 strengthens the company's competitive position.
- The business model supports ample room to invest in growth with an average gross margin of 60.5%.